Free Trial
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free CTOR Stock Alerts

Citius Oncology (CTOR) Institutional Ownership

Citius Oncology logo
$0.84 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$0.84 0.00 (-0.46%)
As of 05/22/2026 06:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Citius Oncology (NASDAQ:CTOR)

Current
Institutional Ownership
Percentage
70.52%
Number of
Institutional Buyers
(last 12 months)
8
Total
Institutional Inflows
(last 12 months)
$18.94M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$2.14M
Get CTOR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Citius Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CTOR Institutional Buying and Selling by Quarter

Citius Oncology Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE3,835,160$2.37M0.0%+1,792,030.8%4.344%
2/18/2026 XTX Topco Ltd73,992$74K0.0%-41.7%0.084%
2/18/2026 Armistice Capital LLC5,584,080$5.58M0.1%-27.3%6.325%
2/16/2026 OMERS ADMINISTRATION Corp104,500$104K0.0%N/A0.118%
2/9/2026 Geode Capital Management LLC220,047$220K0.0%+31.6%0.249%
2/6/2026 IFP Advisors Inc87,424$87K0.0%+163.2%0.099%
12/2/2025 IFP Advisors Inc33,215$67K0.0%+49.5%0.039%
11/17/2025 Armistice Capital LLC7,675,911$15.58M0.2%N/A9.192%
11/17/2025 Citadel Advisors LLC17,661$36K0.0%N/A0.021%
8/15/2025 Bank of America Corp DE8,571$37K0.0%+5,256.9%0.011%
8/14/2025 Jane Street Group LLC106,970$465K0.0%N/A0.136%
8/8/2025 Geode Capital Management LLC57,297$249K0.0%+179.0%0.073%
8/4/2025 Arkadios Wealth Advisors11,666$51K0.0%N/A0.015%
2/17/2025Citadel Advisors LLC22,699$26K0.0%N/A0.032%
2/4/2025IFP Advisors Inc22,215$26K0.0%+173.1%0.031%


CTOR Institutional Ownership - Frequently Asked Questions

During the previous two years, 9 institutional investors and hedge funds held shares of Citius Oncology. The most heavily invested institutionals were Armistice Capital LLC ($5.58M), Bank of America Corp DE ($2.37M), Jane Street Group LLC ($465K), Geode Capital Management LLC ($220K), OMERS ADMINISTRATION Corp ($104K), IFP Advisors Inc ($87K), and XTX Topco Ltd ($74K).Learn more on Citius Oncology's institutional investors.

70.52% of Citius Oncology's stock is owned by institutional investors. Learn more on CTOR's institutional investor holdings.

The following institutional investors have purchased Citius Oncology's stock in the last 24 months: Armistice Capital LLC ($7.68M), Bank of America Corp DE ($3.84M), Jane Street Group LLC ($106.97K), OMERS ADMINISTRATION Corp ($104.50K), Geode Capital Management LLC ($89.63K), IFP Advisors Inc ($79.29K), and Citadel Advisors LLC ($40.36K).

Institutional investors have bought a total of 11,914,907 shares in the last 24 months. This purchase volume represents approximately $18.94M in transactions.

The following institutional investors have sold Citius Oncology stock in the last 24 months: Armistice Capital LLC ($2.09M), and XTX Topco Ltd ($52.89K).

Institutional investors have sold a total of 2,144,723 shares in the last 24 months. This volume of shares sold represents approximately $2.14M in transactions.


Related Companies

This page (NASDAQ:CTOR) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
The S-1 just dropped. 22 days left.
The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...
Behind the Markets | Sponsoredtc pixel
My crisis of conscience
Emmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...
InvestorPlace | Sponsoredtc pixel
Opportunity Forming in a U.S. Supply-Chain Weak Spot?
America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...
i2i Marketing Group, LLC | Sponsoredtc pixel